New Approaches to the Drug Molecule: Essential Oil and Pyridazinone Derivative Molecules
Abstract
Keywords
Alzheimer , Essential oil , Microencapsulation , PLGA , Pyridazinone
References
- Sang, Z., Wang, K., Dong, J., & Tang, L. (2022). Alzheimer’s disease: Updated multi-targets therapeutics are in clinical and in progress. European Journal of Medicinal Chemistry, 238.
- Breijyeh, Z., & Karaman, R. (2020b). Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules (Basel, Switzerland), 25(24).
- Areosa Sastre, A., Sherriff, F., & McShane, R. (2005). Memantine for dementia. The Cochrane Database of Systematic Reviews, 3.
- Fish, P. V., Steadman, D., Bayle, E. D., & Whiting, P. (2019b). New approaches for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters, 29(2), 125–133.
- Alghamdi, S., & Asif, M. (2021). Role of pyridazine analogs as acetylcholinesterase inhibitor: An approach for management of alzheimer’s disease. Eurasian Chemical Communications, 3(7), 435–442.
- Kilic, B., Erdogan, M., Gulcan, H. O., Aksakal, F., Oruklu, N., Bagriacik, E. U., & Dogruer, D. S. (2019). Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors. Medicinal Chemistry (Shariqah (United Arab Emirates)), 15(1), 59–76.
- Soheili, M., & Salami, M. (2019). Lavandula angustifolia biological characteristics: An in vitro study. Journal of Cellular Physiology, 234(9), 16424–16430.
- Xu, Q., Wang, Y., Xu, J., Sun, M., Tian, H., Zuo, D., Guan, Q., Bao, K., Wu, Y., & Zhang, W. (2016). Synthesis and Bioevaluation of 3,6-Diaryl-[1,2,4]triazolo[4,3-b] Pyridazines as Antitubulin Agents. ACS Medicinal Chemistry Letters, 7(12), 1202–1206.
- Botvin, V., Karaseva, S., Salikova, D., & Dusselier, M. (2021). Syntheses and chemical transformations of glycolide and lactide as monomers for biodegradable polymers. Polymer Degradation and Stability, 183, 109427.
- Pan, Z., & Ding, J. (2012). Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine. Interface Focus, 2(3), 366–377.